Translational applications and clinical utility of organoids in ovarian cancer: a systematic review
This systematic review synthesized data from 13 studies evaluating the feasibility, histological fidelity, and clinical concordance of ovarian cancer patient-derived organoids to suggest PDOs represent a robust platform for functional drug screening within a clinically actionable 21-day window.